Last updated: March 29, 2021
Sponsor: NYU Langone Health
Overall Status: Completed
Phase
N/A
Condition
Traumatic Brain Injury
Stroke
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT02507271
10-01918
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Mild, moderate and severe traumatic brain injury or a cerebral vascular accident (Stroke)
- All subjects will be between the ages of 18 and 70 years
- Free from significant psychiatric history (such as schizophrenia or bipolar disorder),due to the potential influence of such disorders on cognitive functioning
- Free of current alcohol or drug as these factors have been shown to negatively affectcognitive abilities.
Exclusion
Exclusion Criteria:
- Potential participants will be excluded if they are currently taking benzodiazepinesor neuroleptics due to their potential effects on cognition.
- Participant will be excluded if they are unable to comprehend the English language,either verbally or written.
- Participants will be excluded from the magnetic resonance imaging (MRI) scan portionof the study if they contain metal in their body that is not compatible with the MRIscan.
Study Design
Total Participants: 100
Study Start date:
August 01, 2010
Estimated Completion Date:
March 25, 2021
Study Description
Connect with a study center
NYU Langone Medical Center, Rusk Institute for Rehabilitation
New York, New York 10016
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.